First Header Logo Second Header Logo

Connection

Steven Feldman to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Randomized Controlled Trials as Topic.
Steven Feldman
Connection Strength
2.765
Randomized Controlled Trials as Topic
  1. Cohen SR, Pona A, Cline AE, Feldman SR. The complexity of adverse event assessment and counseling for patients on biologic treatment. Expert Rev Clin Immunol. 2019 08; 15(8):809-811.
    View in: PubMed
    Score: 0.563
  2. Garduno J, Bhosle MJ, Balkrishnan R, Feldman SR. Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review. J Dermatolog Treat. 2007; 18(4):223-42.
    View in: PubMed
    Score: 0.236
  3. Stein Gold LF, Takiya L, Zang C, Sanders P, Feldman SR. Demographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis. J Drugs Dermatol. 2020 Jun 01; 19(6):619-624.
    View in: PubMed
    Score: 0.150
  4. Mendes JT, Balogh EA, Strowd LC, Feldman SR. An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis. Expert Opin Pharmacother. 2020 Jun; 21(9):1027-1033.
    View in: PubMed
    Score: 0.148
  5. Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019 Feb; 80(2):411-416.e4.
    View in: PubMed
    Score: 0.134
  6. Howell ST, Cardwell LA, Feldman SR. Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials. Ann Pharmacother. 2018 04; 52(4):380-387.
    View in: PubMed
    Score: 0.126
  7. Vera N, Patel N, Cardwell LA, Saleem M, Feldman SR. Chemical pharmacotherapy options for managing adult acne. Expert Opin Pharmacother. 2017 Feb; 18(3):263-273.
    View in: PubMed
    Score: 0.119
  8. Aslam I, Sandoval LF, Feldman SR. What's new in the topical treatment of allergic skin diseases. Curr Opin Allergy Clin Immunol. 2014 Oct; 14(5):436-50.
    View in: PubMed
    Score: 0.101
  9. Moustafa FA, Sandoval LF, Feldman SR. Rosacea: new and emerging treatments. Drugs. 2014 Sep; 74(13):1457-65.
    View in: PubMed
    Score: 0.101
  10. Sandoval LF, Pierce A, Feldman SR. Systemic therapies for psoriasis: an evidence-based update. Am J Clin Dermatol. 2014 Jul; 15(3):165-80.
    View in: PubMed
    Score: 0.099
  11. Snyder S, Crandell I, Davis SA, Feldman SR. Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol. 2014 Apr; 15(2):87-94.
    View in: PubMed
    Score: 0.098
  12. West C, Narahari S, O'Neill J, Davis S, Huynh M, Clark A, Boles A, Feldman SR. Adherence to adalimumab in patients with moderate to severe psoriasis. Dermatol Online J. 2013 May 15; 19(5):18182.
    View in: PubMed
    Score: 0.092
  13. Tan X, Balkrishnan R, Feldman SR. Infections associated with the use of tumor necrosis factor-a inhibitors in psoriasis. J Drugs Dermatol. 2013 Mar; 12(3):e41-5.
    View in: PubMed
    Score: 0.091
  14. Staidle JP, Dabade TS, Feldman SR. A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opin Pharmacother. 2011 Sep; 12(13):2041-54.
    View in: PubMed
    Score: 0.081
  15. Levender MM, Feldman SR. Importance of providing adequate patient information to ensure good adherence and outcomes: comment on "Efficacy of an educational intervention with kidney transplant recipients to promote skin self-examination for squamous cell carcinoma detection". Arch Dermatol. 2011 Jun; 147(6):695-6.
    View in: PubMed
    Score: 0.080
  16. Feldman SR, Tan J, Poulin Y, Dirschka T, Kerrouche N, Manna V. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. J Am Acad Dermatol. 2011 Jun; 64(6):1085-91.
    View in: PubMed
    Score: 0.079
  17. Rajpara AN, O'Neill JL, Nolan BV, Yentzer BA, Feldman SR. Review of home phototherapy. Dermatol Online J. 2010 Dec 15; 16(12):2.
    View in: PubMed
    Score: 0.078
  18. Pearce DJ, Klinger S, Ziel KK, Murad EJ, Rowell R, Feldman SR. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis. Arch Dermatol. 2006 Aug; 142(8):1000-4.
    View in: PubMed
    Score: 0.057
  19. Warino L, Balkrishnan R, Feldman SR. Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol. 2006 Jun; 5(6):527-32.
    View in: PubMed
    Score: 0.057
  20. Krob AH, Fleischer AB, D'Agostino R, Feldman SR. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials. J Cutan Med Surg. 2003 Jul-Aug; 7(4):306-11.
    View in: PubMed
    Score: 0.046
  21. Wilson JK, Al-Suwaidan SN, Krowchuk D, Feldman SR. Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol. 2003 Jan-Feb; 20(1):11-5.
    View in: PubMed
    Score: 0.045
  22. Chan AA, Noguti J, Yang CT, Feldman SR, Wallace RB, Shadyab AH, Manson JE, Aragaki AK, Chlebowski RT, Lee DJ. Association between menopausal hormone therapy and incidence of psoriasis: a secondary analysis from the Women's Health Initiative randomized clinical trials. Br J Dermatol. 2021 09; 185(3):669-671.
    View in: PubMed
    Score: 0.040
  23. Mahadevan U, Dubinsky MC, Su C, Lawendy N, Jones TV, Marren A, Zhang H, Graham D, Clowse MEB, Feldman SR, Baumgart DC. Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. Inflamm Bowel Dis. 2018 11 29; 24(12):2494-2500.
    View in: PubMed
    Score: 0.034
  24. Clowse ME, Feldman SR, Isaacs JD, Kimball AB, Strand V, Warren RB, Xibillé D, Chen Y, Frazier D, Geier J, Proulx J, Marren A. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis. Drug Saf. 2016 08; 39(8):755-62.
    View in: PubMed
    Score: 0.029
  25. Papp KA, Krueger JG, Feldman SR, Langley RG, Thaci D, Torii H, Tyring S, Wolk R, Gardner A, Mebus C, Tan H, Luo Y, Gupta P, Mallbris L, Tatulych S. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study. J Am Acad Dermatol. 2016 May; 74(5):841-50.
    View in: PubMed
    Score: 0.028
  26. Kim IH, West CE, Kwatra SG, Feldman SR, O'Neill JL. Comparative efficacy of biologics in psoriasis: a review. Am J Clin Dermatol. 2012 Dec 01; 13(6):365-74.
    View in: PubMed
    Score: 0.022
  27. Bansback N, Sizto S, Sun H, Feldman S, Willian MK, Anis A. Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis. Dermatology. 2009; 219(3):209-18.
    View in: PubMed
    Score: 0.018
  28. Price J, Bhosle M, Feldman SR, Balkrishnan R. Outcomes associated with the use of biologic agents in moderate to severe psoriasis. J Drugs Dermatol. 2007 Mar; 6(3):259-67.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.